The Journal of Allergy and Clinical Immunology
Volume 111, Issue 1 , Pages 155-161 , January 2003

A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract

Received 23 June 2002 ,Revised 27 September 2002 ,Accepted 10 October 2002.

  • Image Result

    Changes in titrated skin prick test results. Shown are the changes in threshold of titrated skin prick tests to cat allergen extract from before immunotherapy to after the first maintenance injection.

    Changes in titrated skin prick test results. Shown are the changes in threshold of titrated skin prick tests to cat allergen extract from before immunotherapy to after the first maintenance injection. The overall dose effect is significant (P = .008), as are the changes with 3.0 μg (P = .02) and 15.0 μg (P = .002).

  • Image Result
    Increases from baseline to after the first maintenance injection in serum cat allergen–specific IgG4. The overall dose effect is significant (P = .01), as are the changes with 3.0 μg (P = .01) and 15.

    Increases from baseline to after the first maintenance injection in serum cat allergen–specific IgG4. The overall dose effect is significant (P = .01), as are the changes with 3.0 μg (P = .01) and 15.0 μg (P = .006).

  • Image Result
    Changes from baseline to after the first maintenance injection in the percent of PBMCs positive for CD4 and IL-4 (by flow cytometry). The overall dose effect is significant (P = .03), as is the result

    Changes from baseline to after the first maintenance injection in the percent of PBMCs positive for CD4 and IL-4 (by flow cytometry). The overall dose effect is significant (P = .03), as is the result with 15.0 μg (P = .003).

 Reprint requests: Harold S. Nelson, MD, National Jewish Medical and Research Center, 1400 Jackson St, Denver, CO 80206.

PII: S0091-6749(02)91303-5

doi: 10.1067/mai.2003.41

The Journal of Allergy and Clinical Immunology
Volume 111, Issue 1 , Pages 155-161 , January 2003